Literature DB >> 23178226

Plasma plant sterols serve as poor markers of cholesterol absorption in man.

Lily Jakulj1, Hussein Mohammed, Theo H van Dijk, Theo Boer, Scott Turner, Albert K Groen, Maud N Vissers, Erik S G Stroes.   

Abstract

The validation of the use of plasma plant sterols as a marker of cholesterol absorption is frail. Nevertheless, plant sterol concentrations are routinely used to describe treatment-induced changes in cholesterol absorption. Their use has also been advocated as a clinical tool to tailor cholesterol-lowering therapy. Prior to wider implementation, however, the validity of plant sterols as absorption markers needs solid evaluation. Therefore, we compared plasma plant sterol concentrations to gold-standard stable isotope-determined cholesterol absorption. Plasma campesterol/TC concentrations (camp/TC) were measured in a population of 175 mildly hypercholesterolemic individuals (age: 59.7 ± 5.6 years; BMI: 25.5 ± 2.9 kg/m(2); LDL-C: 4.01 ± 0.56 mmol/l). We compared cholesterol absorption according to the plasma dual-isotope method in subjects with the highest camp/TC concentrations (N = 41, camp/TC: 2.14 ± 0.68 μg/mg) and the lowest camp/TC concentrations (N = 39, camp/TC: 0.97 ± 0.22 μg/mg). Fractional cholesterol absorption did not differ between the groups (24 ± 12% versus 25 ± 16%, P = 0.60), nor was it associated with plasma camp/TC concentrations in the total population of 80 individuals (β = 0.13; P = 0.30, adjusted for BMI and plasma triglycerides). Our findings do not support a relation between plasma plant sterol concentrations and true cholesterol absorption and, therefore, do not favor the use of these sterols as markers of cholesterol absorption. This bears direct consequences for the interpretation of earlier studies, as well as for future studies targeting intestinal regulation of cholesterol metabolism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23178226      PMCID: PMC3605990          DOI: 10.1194/jlr.P031021

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  54 in total

1.  LXR/RXR ligand activation enhances basolateral efflux of beta-sitosterol in CaCo-2 cells.

Authors:  F Jeffrey Field; Ella Born; Satya N Mathur
Journal:  J Lipid Res       Date:  2004-03-01       Impact factor: 5.922

2.  Introducing a new component of the metabolic syndrome: low cholesterol absorption.

Authors:  P Simonen; H Gylling; A N Howard; T A Miettinen
Journal:  Am J Clin Nutr       Date:  2000-07       Impact factor: 7.045

3.  Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol.

Authors:  T A Miettinen; T E Strandberg; H Gylling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 5.  Plasma concentrations of plant sterols: physiology and relationship with coronary heart disease.

Authors:  Yen-Ming Chan; Krista A Varady; Yuguang Lin; Elke Trautwein; Ronald P Mensink; Jogchum Plat; Peter J H Jones
Journal:  Nutr Rev       Date:  2006-09       Impact factor: 7.110

6.  Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men.

Authors:  Jussi Pihlajamäki; Helena Gylling; Tatu A Miettinen; Markku Laakso
Journal:  J Lipid Res       Date:  2003-12-01       Impact factor: 5.922

7.  Metabolism of beta-sitosterol in man.

Authors:  G Salen; E H Ahrens; S M Grundy
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

Review 8.  Approaches to measuring cholesterol absorption in humans.

Authors:  Nirupa R Matthan; Alice H Lichtenstein
Journal:  Atherosclerosis       Date:  2004-06       Impact factor: 5.162

Review 9.  Determination of cholesterol absorption in humans: from radiolabel to stable isotope studies.

Authors:  E Pouteau; C Piguet-Welsch; A Berger; L B Fay
Journal:  Isotopes Environ Health Stud       Date:  2003-12       Impact factor: 1.675

10.  Sitosterolemia in ABC-transporter G5-deficient mice is aggravated on activation of the liver-X receptor.

Authors:  Torsten Plösch; Vincent W Bloks; Yuko Terasawa; Sara Berdy; Karen Siegler; Fjodor Van Der Sluijs; Ido P Kema; Albert K Groen; Bei Shan; Folkert Kuipers; Margrit Schwarz; Margrit Schwartz
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

View more
  5 in total

1.  Plasma noncholesterol sterols as indicators of cholesterol absorption.

Authors:  Scott M Grundy
Journal:  J Lipid Res       Date:  2013-02-12       Impact factor: 5.922

2.  Comparison of phytosterol intake from FFQ with repeated 24-h dietary recalls of the Adventist Health Study-2 calibration sub-study.

Authors:  Rawiwan Sirirat; Celine Heskey; Ella Haddad; Yessenia Tantamango-Bartley; Gary Fraser; Andrew Mashchak; Karen Jaceldo-Siegl
Journal:  Br J Nutr       Date:  2019-03-20       Impact factor: 3.718

3.  Association between cholesterol synthesis/absorption markers and effects of cholesterol lowering by atorvastatin among patients with high risk of coronary heart disease.

Authors:  Yue Qi; Jing Liu; Changsheng Ma; Wei Wang; Xiaohui Liu; Miao Wang; Qiang Lv; Jiayi Sun; Jun Liu; Yan Li; Dong Zhao
Journal:  J Lipid Res       Date:  2013-08-20       Impact factor: 5.922

4.  Cholesterol metabolism and serum non-cholesterol sterols: summary of 13 plant stanol ester interventions.

Authors:  Maarit Hallikainen; Piia Simonen; Helena Gylling
Journal:  Lipids Health Dis       Date:  2014-04-27       Impact factor: 3.876

5.  Plasma lathosterol measures rates of cholesterol synthesis and efficiency of dietary phytosterols in reducing the plasma cholesterol concentration.

Authors:  Valéria Sutti Nunes; Angela de Oliveira Godoy Ilha; Guilherme da Silva Ferreira; Renata de Paula Assis Bombo; Milessa Silva Afonso; Maria Silvia Ferrari Lavrador; Roberta Marcondes Machado; Edna Regina Nakandakare; Eder Carlos Rocha Quintão; Ana Maria Lottenberg
Journal:  Clinics (Sao Paulo)       Date:  2022-04-06       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.